Literature DB >> 3965501

Stereospecific transport of triiodothyronine from plasma to cytosol and from cytosol to nucleus in rat liver, kidney, brain, and heart.

J H Oppenheimer, H L Schwartz.   

Abstract

We have investigated the transport of L- and D-triiodothyronine (T3) from plasma to cellular cytoplasm and from cytoplasm to nucleus by estimating the concentration of free hormone in these compartments in rat liver, kidney, brain, and heart. We assessed the distribution of T3 in various tissues and its metabolism by standard isotopic techniques and measured plasma and cytosolic tissue T3 by radioimmunoassay. In addition, we determined the fraction of radiosensitive T3 associated with the cytosol in individual tissues and estimated the cytosolic volume per gram of tissue. Equilibrium dialysis allowed us to determine the binding power of cytosols and plasma, and in vitro saturation techniques provided values for the affinity (ka) for L- and D-T3 of isolated nuclei in aqueous solution at 37 degrees C. We calculated the free cytosolic hormone from the product of cytosolic T3 and the binding power of cytosol for T3, and the free intranuclear T3 from the ka and previously determined ratio of occupied-to-unoccupied binding sites under steady state conditions in euthyroid animals. Our results showed that the free cytosolic/free plasma concentrations for L-T3 and D-T3, respectively, were: liver 2.8, 21.6; kidney 1.17, 63.3; heart 1.31, 1.58; brain 0.86, 0.24. The free nuclear/free cytosolic ratios for L-T3 and D-T3, respectively, were: liver 58.2, 3.70; kidney 55.9, 1.54; heart 80.6, 24.9; and brain 251, 108.6. Our findings suggest that stereospecific transport occurs both from plasma to cytosol and from cytosol to nucleus. The high gradients from cytosol to nucleus imply that there is an energy-dependent process and appear to account for the differences in the nuclear association constant determined in vivo and in vitro.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3965501      PMCID: PMC423420          DOI: 10.1172/JCI111667

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  28 in total

1.  In vitro binding of L-triiodothyronine to receptors in rat liver nuclei. Kinectics of binding, extraction properties, and lack of requirement for cytosol proteins.

Authors:  M I Surks; D H Koerner; J H Oppenheimer
Journal:  J Clin Invest       Date:  1975-01       Impact factor: 14.808

2.  Triiodothyronine binding to isolated liver cell nuclei.

Authors:  L J DeGroot; J Torresani
Journal:  Endocrinology       Date:  1975-02       Impact factor: 4.736

3.  Uptake of thyroid hormone by isolated rat liver cells.

Authors:  G S Rao; J Eckel; M L Rao; H Breuer
Journal:  Biochem Biophys Res Commun       Date:  1976-11-08       Impact factor: 3.575

4.  Tissue differences in the concentration of triiodothyronine nuclear binding sites in the rat: liver, kidney, pituitary, heart, brain, spleen, and testis.

Authors:  J H Oppenheimer; H L Schwartz; M I Surks
Journal:  Endocrinology       Date:  1974-09       Impact factor: 4.736

5.  An improved method for chromatography of iodothyronines.

Authors:  D Bellabarba; R E Peterson; K Sterling
Journal:  J Clin Endocrinol Metab       Date:  1968-02       Impact factor: 5.958

6.  The metabolic significance of exchangeable cellular thyroxine.

Authors:  J H Oppenheimer; M I Surks; H L Schwartz
Journal:  Recent Prog Horm Res       Date:  1969

7.  Differences in primary cellular factors influencing the metabolism and distribution of 3,5,3'-L-triiodothyronine and L-thyroxine.

Authors:  J H Oppenheimer; H L Schwartz; H C Shapiro; G Bernstein; M I Surks
Journal:  J Clin Invest       Date:  1970-05       Impact factor: 14.808

8.  A new radioimmunoassay for plasma L-triiodothyronine: measurements in thyroid disease and in patients maintained on hormonal replacement.

Authors:  M I Surks; A R Schadlow; J H Oppenheimer
Journal:  J Clin Invest       Date:  1972-12       Impact factor: 14.808

9.  Thyroid hormone action: in vitro characterization of solubilized nuclear receptors from rat liver and cultured GH1 cells.

Authors:  H H Samuels; J S Tsai; J Casanova; F Stanley
Journal:  J Clin Invest       Date:  1974-10       Impact factor: 14.808

10.  Limited binding capacity sites for L-triiodothyronine in rat liver nuclei. Nuclear-cytoplasmic interrelation, binding constants, and cross-reactivity with L-thyroxine.

Authors:  J H Oppenheimer; H L Schwartz; D Koerner; M I Surks
Journal:  J Clin Invest       Date:  1974-03       Impact factor: 14.808

View more
  22 in total

1.  Cytosolic thyroid hormone-binding protein is a monomer of pyruvate kinase.

Authors:  H Kato; T Fukuda; C Parkison; P McPhie; S Y Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

2.  Dissociated thyromimetic effects of 3, 5, 3'-triiodothyroacetic acid (TRIAC) at the pituitary and peripheral tissue levels.

Authors:  P Beck-Peccoz; A Sartorio; C De Medici; G Grugni; F Morabito; G Faglia
Journal:  J Endocrinol Invest       Date:  1988-02       Impact factor: 4.256

Review 3.  Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling.

Authors:  Balázs Gereben; Ann Marie Zavacki; Scott Ribich; Brian W Kim; Stephen A Huang; Warner S Simonides; Anikó Zeöld; Antonio C Bianco
Journal:  Endocr Rev       Date:  2008-09-24       Impact factor: 19.871

Review 4.  Paradigms of Dynamic Control of Thyroid Hormone Signaling.

Authors:  Antonio C Bianco; Alexandra Dumitrescu; Balázs Gereben; Miriam O Ribeiro; Tatiana L Fonseca; Gustavo W Fernandes; Barbara M L C Bocco
Journal:  Endocr Rev       Date:  2019-08-01       Impact factor: 19.871

5.  Identification of a new hormone-binding site on the surface of thyroid hormone receptor.

Authors:  P C T Souza; A C Puhl; L Martínez; R Aparício; A S Nascimento; A C M Figueira; P Nguyen; P Webb; M S Skaf; I Polikarpov
Journal:  Mol Endocrinol       Date:  2014-02-19

6.  Internalization of triiodothyronine-bovine serum albumin-colloidal gold complexes in human peripheral leukocytes.

Authors:  Z Kostrouch; I Raska; V Felt; J Nedvídková; E Holecková
Journal:  Experientia       Date:  1987-10-15

Review 7.  Thyroid hormone transporters--functions and clinical implications.

Authors:  Juan Bernal; Ana Guadaño-Ferraz; Beatriz Morte
Journal:  Nat Rev Endocrinol       Date:  2015-05-05       Impact factor: 43.330

8.  Studies on the possible role of thyroid hormone in altered muscle protein turnover during sepsis.

Authors:  P O Hasselgren; I W Chen; J H James; M Sperling; B W Warner; J E Fischer
Journal:  Ann Surg       Date:  1987-07       Impact factor: 12.969

9.  Furosemide, fenclofenac, diclofenac, mefenamic acid and meclofenamic acid inhibit specific T3 binding in isolated rat hepatic nuclei.

Authors:  D J Topliss; P S Hamblin; E Kolliniatis; C F Lim; J R Stockigt
Journal:  J Endocrinol Invest       Date:  1988-05       Impact factor: 4.256

10.  Regulation of thyroid hormone receptor-mediated transcription by a cytosol protein.

Authors:  K Ashizawa; S Y Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.